Evidence map›Paper›PMID 15701808›Full record

ArticleEukaryotic cell2005

Radiological studies reveal radial differences in the architecture of the polysaccharide capsule of Cryptococcus neoformans.

R A Bryan, O Zaragoza, T Zhang, G Ortiz, A Casadevall, E Dadachova

Open access · diamondAbstract read
In one paragraph

Article in Eukaryotic cell, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 84 citations in OpenAlex.

  1. Cell wall melanin impedes growth of theProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  2. Neutron Scattering Analysis ofBiomacromolecules · 2024
    Article
  3. Article
  4. Neutron Scattering Analysis ofbioRxiv : the preprint server for biology · 2023
    Article
  5. Article
  6. Article
  7. Influence of Pathogen Carbon Metabolism on Interactions With Host Immunity.Frontiers in cellular and infection microbiology · 2022
    Review
  8. The Antimicrobial Peptide MK58911-NHAntimicrobial agents and chemotherapy · 2021
    Article
  9. Ultrastructural Study ofFrontiers in microbiology · 2021
    Article
  10. ExploringThe Journal of biological chemistry · 2020
    Article
  11. Mediators of inflammation · 2020
    Article
  12. Review
  13. The capsule ofVirulence · 2019
    Review
  14. Article
  15. Macrolides Inhibit Capsule Formation of Highly VirulentAntimicrobial agents and chemotherapy · 2019
    Article
  16. The Buoyancy ofmSphere · 2018
    Article
  17. Review
  18. Article
  19. Article
  20. Dectin-3 Recognizes Glucuronoxylomannan ofFrontiers in immunology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

R A BryanDepartment of Nuclear Medicine, Albert Einstein College of Medicine, 1695A Eastchester Rd., Bronx, NY 10461, USA.
O Zaragoza
T Zhang
G Ortiz
A Casadevall
E Dadachova
Bipar · FR

Funding

Synergy of Host Defense Mechanisms in the LungR01HL059842 · NHLBI · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1997 to 2023
$7.4M
PROTECTIVE ANTIBODIES FOR CRYPTOCOCCAL INFECTIONSR01AI033774 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1994 to 2014
$5.6M
Molecular Characterization of C. neoformans AntibodiesR37AI033142 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CASADEVALL, ARTURO · 2007 to 2016
$3.9M
MOLECULAR CHARACTERIZATION OF C NEOFORMANS ANTIBODIESR01AI033142 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1994 to 2006
$1.7M
Radioimmunotherapy of opportunistic infectionsR21AI052042 · NIAID · YESHIVA UNIVERSITY · PI DADACHOVA, EKATERINA · 2002 to 2003
$501k
NHLBI NIH HHS HL059842NHLBI NIH HHS R01 HL059842NIAID NIH HHS AI033142NIAID NIH HHS AI03374NIAID NIH HHS AI52042NIAID NIH HHS R01 AI033142NIAID NIH HHS R01 AI033774NIAID NIH HHS R21 AI052042NIAID NIH HHS R37 AI033142
6 · The paper itself

Abstract

The polysaccharide capsule of the pathogenic fungus Cryptococcus neoformans is an important virulence factor, but relatively little is known about its architecture. We applied a combination of radiological, chemical, and serological methods to investigate the structure of this polysaccharide capsule. Exposure of C. neoformans cells to gamma radiation, dimethyl sulfoxide, or radiolabeled monoclonal antibody removed a significant part of the capsule. Short intervals of gamma irradiation removed the outer portion of the cryptococcal capsule without killing cells, which could subsequently repair their capsules. Survival analysis of irradiated wild-type, acapsular mutant, and complemented mutant strains demonstrated that the capsule contributed to radioprotection and had a linear attenuation coefficient higher than that of lead. The capsule portions remaining after dimethyl sulfoxide or gamma radiation treatment were comparable in size, 65 to 66 microm3, and retained immunoreactivity for a monoclonal antibody to glucuronoxylomannan. Simultaneous or sequential treatment of the cells with dimethyl sulfoxide and radiation removed the remaining capsule so that it was not visible by light microscopy. The capsule could be protected against radiation by either of the free radical scavengers ascorbic acid and sorbitol. Sugar composition analysis of polysaccharide removed from the outer and inner parts of the capsule revealed significant differences in glucuronic acid and xylose molar ratios, implying differences in the chemical structure of the constituent polysaccharides. Our results provide compelling evidence for the existence of two zones in the C. neoformans capsule that differ in susceptibility to dimethyl sulfoxide and radiation and, possibly, in packing and composition.

Indexed as

Bacterial CapsulesCryptococcus neoformansAntibodies, MonoclonalAntioxidantsAscorbic AcidCell SurvivalDimethyl SulfoxideGamma RaysHumansIndicators and ReagentsPolysaccharides, BacterialSolventsSorbitolAntibodies, MonoclonalAntioxidantsAscorbic AcidDimethyl SulfoxideIndicators and ReagentsPolysaccharides, BacterialSolventsSorbitol

Identifiers

PMID15701808
PMCPMC549344
OpenAlexW2134546075

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.